Gliomas Completed Phase 1 Trials for Irinotecan (DB00762)

Also known as: Glioma / [M]Glioma NOS

IndicationStatusPhase
DBCOND0032593 (Gliomas)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01999270Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS TumorsTreatment